Back to Directory Ting-Li Lin Email tlin@sdac.harvard.edu Institution Statistical and Data Analysis Center Title Senior Statistician Request an Update Affiliated Studies IMPAACT 2051: Phase II Study of the Pharmacokinetics, Safety, Tolerability, and Anti-Mycobacterial Activity of Pretomanid with Bedaquiline and Linezolid, with or without Moxifloxacin, in Children with Rifampicin-Resistant Tuberculosis DAIDS Number 39258 Research Area Tuberculosis Study Status In Development IMPAACT 2034: Phase 1 Study of the Pharmacokinetics, Safety, and Acceptability of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children with Rifampicin-Resistant Tuberculosis DAIDS Number 38754 Research Area Tuberculosis Study Status Participants Off Study and Primary Analysis Completed
IMPAACT 2051: Phase II Study of the Pharmacokinetics, Safety, Tolerability, and Anti-Mycobacterial Activity of Pretomanid with Bedaquiline and Linezolid, with or without Moxifloxacin, in Children with Rifampicin-Resistant Tuberculosis DAIDS Number 39258 Research Area Tuberculosis Study Status In Development
IMPAACT 2034: Phase 1 Study of the Pharmacokinetics, Safety, and Acceptability of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children with Rifampicin-Resistant Tuberculosis DAIDS Number 38754 Research Area Tuberculosis Study Status Participants Off Study and Primary Analysis Completed
